Summary
Quest Diagnostics Incorporated (DGX) filed an 8-K on February 3, 2022, primarily to report its fourth quarter and full-year 2021 financial results and announce a dividend increase. The company reported its performance for the period ending December 31, 2021, with detailed financial results included in the referenced press release. Investors should review this press release for specific revenue, earnings, and operational metrics.
Key Highlights
- 1Announcement of Q4 and Full Year 2021 Financial Results.
- 2Press release detailing financial performance for the period ending December 31, 2021, is incorporated by reference.
- 3Board of Directors increased the quarterly dividend from $0.62 to $0.66 per share.
- 4The dividend increase represents a 6.5% rise.
- 5This marks the eleventh dividend increase for Quest Diagnostics since 2011.
- 6The increased dividend is effective for the payment on April 20, 2022, to shareholders of record on April 6, 2022.
Frequently Asked Questions
The 8-K filing refers to a press release dated February 3, 2022, which contains the company's financial results for the quarter and full year ended December 31, 2021. Investors should consult this press release (Exhibit 99.1) for specific revenue, earnings per share, and other financial performance indicators.
Quest Diagnostics' Board of Directors approved an increase in the quarterly dividend from $0.62 to $0.66 per share.
The increased quarterly dividend of $0.66 per share is effective with the dividend payable on April 20, 2022, to shareholders who are on record as of April 6, 2022.
The 6.5% increase in the quarterly dividend is the company's eleventh such increase since 2011, indicating a consistent commitment to returning capital to shareholders and reflecting confidence in the company's financial health and future prospects.